Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             97 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC McKenzie, Robin
2008
26 Supplement 10 p. 4731-4739
9 p.
artikel
2 A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6 weeks in Côte d’Ivoire Ekra, Daniel
2008
26 Supplement 10 p. 2753-2761
9 p.
artikel
3 Appropriate tetanus prophylaxis practices in patients attending Emergency Departments in Italy Abbate, Rossella
2008
26 Supplement 10 p. 3634-3639
6 p.
artikel
4 A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats McEachern, Jennifer A.
2008
26 Supplement 10 p. 3842-3852
11 p.
artikel
5 A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial Martin, Julie E.
2008
26 Supplement 10 p. 6338-6343
6 p.
artikel
6 A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge Klas, S.D.
2008
26 Supplement 10 p. 5494-5502
9 p.
artikel
7 Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: Preliminary results Dhiman, Neelam
2008
26 Supplement 10 p. 1731-1736
6 p.
artikel
8 Bath vaccination of rainbow trout (Oncorhynchus mykiss Walbaum) against Yersinia ruckeri: Effects of temperature on protection and gene expression Raida, M.K.
2008
26 Supplement 10 p. 1050-1062
13 p.
artikel
9 Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1 Fletcher, Helen A.
2008
26 Supplement 10 p. 5269-5275
7 p.
artikel
10 Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry Wang, L.
2008
26 Supplement 10 p. 3580-3586
7 p.
artikel
11 Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: A systematic review Rodríguez-Cobo, Iria
2008
26 Supplement 10 p. 6768-6776
9 p.
artikel
12 Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques Hirao, Lauren A.
2008
26 Supplement 10 p. 3112-3120
9 p.
artikel
13 Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants Gatchalian, Salvacion
2008
26 Supplement 10 p. 2234-2241
8 p.
artikel
14 Comparison of the immunomodulatory effects of L. donovani and L. major excreted–secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells Revest, Matthieu
2008
26 Supplement 10 p. 6119-6123
5 p.
artikel
15 Compound Chinese herbal medicinal ingredients can enhance immune response and efficacy of RHD vaccine in rabbit Yang, Longsheng
2008
26 Supplement 10 p. 4451-4455
5 p.
artikel
16 Contribution of the glycidic moieties to the haemolytic and adjuvant activity of platycodigenin-type saponins from the root of Platycodon grandiflorum Xie, Yong
2008
26 Supplement 10 p. 3452-3460
9 p.
artikel
17 Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch Frerichs, David M.
2008
26 Supplement 10 p. 2782-2787
6 p.
artikel
18 Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073 Fytili, P.
2008
26 Supplement 10 p. 3818-3826
9 p.
artikel
19 DNA vaccine protects ornamental koi (Cyprinus carpio koi) against North American spring viremia of carp virus Emmenegger, E.J.
2008
26 Supplement 10 p. 6415-6421
7 p.
artikel
20 Effect of sublingual administration of interferon-α on the immune response to influenza vaccination in institutionalized elderly individuals Launay, Odile
2008
26 Supplement 10 p. 4073-4079
7 p.
artikel
21 Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection Parida, S.
2008
26 Supplement 10 p. 3469-3479
11 p.
artikel
22 Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide Huang, Yaoxing
2008
26 Supplement 10 p. 1807-1816
10 p.
artikel
23 Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia Bosch, F. Xavier
2008
26 Supplement 10 p. K1-K16
nvt p.
artikel
24 Erratum to “Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage” [Vaccine 26 (10) (2008) 1271–1273] Erdem, Hakan
2008
26 Supplement 10 p. 5896-
1 p.
artikel
25 Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys Nigatu, Wondatir
2008
26 Supplement 10 p. 4769-4774
6 p.
artikel
26 Evaluation of widely consumed botanicals as immunological adjuvants Ragupathi, Govind
2008
26 Supplement 10 p. 4860-4865
6 p.
artikel
27 EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium Bart, Pierre-Alexandre
2008
26 Supplement 10 p. 3153-3161
9 p.
artikel
28 Expression and purification of a Plasmodium vivax antigen – PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects Siddiqui, Asim A.
2007
26 Supplement 10 p. 96-107
12 p.
artikel
29 Expression of cytokine genes following pre- and post-hatch immunization of chickens with herpesvirus of turkeys Abdul-Careem, Mohamed Faizal
2008
26 Supplement 10 p. 2369-2377
9 p.
artikel
30 FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007 Eichelberger, Maryna
2008
26 Supplement 10 p. 4299-4303
5 p.
artikel
31 Fighting rabies in Africa: The Africa Rabies Expert Bureau (AfroREB) Dodet, Betty
2008
26 Supplement 10 p. 6295-6298
4 p.
artikel
32 Formulation of a live bacterial vaccine for stable room temperature storage results in loss of acid, bile and bile salt resistance Edwards, Alexander D.
2008
26 Supplement 10 p. 5675-5678
4 p.
artikel
33 Gender-specific effects of cytokine gene polymorphisms on childhood vaccine responses Baynam, Gareth
2008
26 Supplement 10 p. 3574-3579
6 p.
artikel
34 Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries Goldie, Sue J.
2008
26 Supplement 10 p. 4080-4093
14 p.
artikel
35 High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74) Alam, Mohammad Tauqeer
2008
26 Supplement 10 p. 3787-3794
8 p.
artikel
36 HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response Starodubova, Elizaveta S.
2008
26 Supplement 10 p. 5170-5176
7 p.
artikel
37 HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination Lin, Hans Hsienhong
2008
26 Supplement 10 p. 3414-3420
7 p.
artikel
38 Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis Khan, Arif Azam
2008
26 Supplement 10 p. 316-332
17 p.
artikel
39 Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene Cenna, Jonathan
2008
26 Supplement 10 p. 6405-6414
10 p.
artikel
40 Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus Li, Peng
2008
26 Supplement 10 p. 5802-5807
6 p.
artikel
41 Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis Ferreira, Josie Haydée L.
2008
26 Supplement 10 p. 677-685
9 p.
artikel
42 Immunogenicity and protective efficacy of a tuberculosis DNA vaccine co-expressing pro-apoptotic caspase-3 Gartner, Tatiana
2008
26 Supplement 10 p. 1458-1470
13 p.
artikel
43 Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6–9 and 10–13 years Schmidt-Ott, Ruprecht
2007
26 Supplement 10 p. 32-40
9 p.
artikel
44 Immunogenicity and safety of aerosolized measles vaccine: Systematic review and meta-analysis Low, Nicola
2008
26 Supplement 10 p. 383-398
16 p.
artikel
45 Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia Saaka, M.
2008
26 Supplement 10 p. 3719-3726
8 p.
artikel
46 Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles Lalitha, P.V.
2008
26 Supplement 10 p. 4526-4535
10 p.
artikel
47 Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis Carrillo, Eugenia
2008
26 Supplement 10 p. 1902-1911
10 p.
artikel
48 Immunological adjuvant effect of Japanese ginseng saponins (JGS) on specific antibody and cellular response to ovalbumin and its haemolytic activities Sun, Yongxu
2008
26 Supplement 10 p. 5911-5917
7 p.
artikel
49 Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction Domínguez, A.
2008
26 Supplement 10 p. 1737-1741
5 p.
artikel
50 Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates Verstrepen, Babs E.
2008
26 Supplement 10 p. 3346-3351
6 p.
artikel
51 Individual return to Leydig cell function after GnRH-immunization of boars Claus, Rolf
2008
26 Supplement 10 p. 4571-4578
8 p.
artikel
52 Influenza-related hospitalisation and death in Australians aged 50 years and older Newall, Anthony T.
2008
26 Supplement 10 p. 2135-2141
7 p.
artikel
53 Influenza vaccine in Hajj pilgrims: Policy issues from field studies Rashid, Harunor
2008
26 Supplement 10 p. 4809-4812
4 p.
artikel
54 Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination Martins, Marina Ângela
2008
26 Supplement 10 p. 1173-1184
12 p.
artikel
55 Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue Sabirov, Albert
2008
26 Supplement 10 p. 1566-1576
11 p.
artikel
56 Isolation of rifampicin resistant Flavobacterium psychrophilum strains and their potential as live attenuated vaccine candidates LaFrentz, Benjamin R.
2008
26 Supplement 10 p. 5582-5589
8 p.
artikel
57 Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age Poovorawan, Yong
2008
26 Supplement 10 p. 1535-1540
6 p.
artikel
58 Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescents Diaz-Mitoma, Francisco
2008
26 Supplement 10 p. 1759-1763
5 p.
artikel
59 Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium Toriniwa, Hiroko
2008
26 Supplement 10 p. 3680-3689
10 p.
artikel
60 Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates Jafarzadeh, A.
2008
26 Supplement 10 p. 269-276
8 p.
artikel
61 Measles serological survey in the Italian population: Interpretation of results using mixture model Rota, Maria Cristina
2008
26 Supplement 10 p. 4403-4409
7 p.
artikel
62 Modulation of immunoproteasome subunits by liposomal lipid A Steers, Nicholas J.
2008
26 Supplement 10 p. 2849-2859
11 p.
artikel
63 Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A Taylor, Claribel P.
2008
26 Supplement 10 p. 3404-3409
6 p.
artikel
64 Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C Batdelger, Dendev
2008
26 Supplement 10 p. 2733-2737
5 p.
artikel
65 OPV cannot eradicate polio from India: Do we need any further evidence? Paul, Yash
2008
26 Supplement 10 p. 2058-2061
4 p.
artikel
66 Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice Ren, Z.J.
2008
26 Supplement 10 p. 1471-1481
11 p.
artikel
67 Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies Zhang, Shoufeng
2008
26 Supplement 10 p. 345-350
6 p.
artikel
68 Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: Not missing the opportunities Nara, Peter L.
2008
26 Supplement 10 p. 6200-6211
12 p.
artikel
69 Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis Katoch, K.
2008
26 Supplement 10 p. 1228-1234
7 p.
artikel
70 Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data Bailleux, F.
2008
26 Supplement 10 p. 3903-3908
6 p.
artikel
71 Production of biologically active CXC chemokines by Lactococcus lactis: Evaluation of its potential as a novel mucosal vaccine adjuvant Cortes-Perez, Naima G.
2008
26 Supplement 10 p. 5778-5783
6 p.
artikel
72 Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice Qu, Daofeng
2008
26 Supplement 10 p. 4541-4548
8 p.
artikel
73 Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions Veits, Jutta
2008
26 Supplement 10 p. 1688-1696
9 p.
artikel
74 Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein Fernandes, Ana Paula
2008
26 Supplement 10 p. 5888-5895
8 p.
artikel
75 Protective immunity induced by rPb27 of Paracoccidioides brasiliensis Reis, B.S.
2008
26 Supplement 10 p. 5461-5469
9 p.
artikel
76 Protective Th1 immune responses against chronic toxoplasmosis induced by a protein–protein vaccine combination but not by its DNA–protein counterpart Jongert, E.
2008
26 Supplement 10 p. 5289-5295
7 p.
artikel
77 Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 Hookworm Vaccine in unexposed adults Bethony, Jeffrey M.
2008
26 Supplement 10 p. 2408-2417
10 p.
artikel
78 Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice Xu, Juan
2008
26 Supplement 10 p. 4519-4525
7 p.
artikel
79 Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults Roukens, A.H.
2008
26 Supplement 10 p. 3438-3442
5 p.
artikel
80 Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2 Kixmöller, Marion
2008
26 Supplement 10 p. 3443-3451
9 p.
artikel
81 Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5–14 years old children Esteghamati, Abdoulreza
2008
26 Supplement 10 p. 5058-5061
4 p.
artikel
82 Setting priorities for new vaccination programs by using public health officers and immunization managers opinions Gilca, Vladimir
2008
26 Supplement 10 p. 4204-4209
6 p.
artikel
83 Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5–49 years of age Block, Stan L.
2008
26 Supplement 10 p. 4940-4946
7 p.
artikel
84 Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia Borkowsky, William
2008
26 Supplement 10 p. 3086-3089
4 p.
artikel
85 The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis Araujo, Zaida
2008
26 Supplement 10 p. 5575-5581
7 p.
artikel
86 The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10 Lu, Xiao-ling
2008
26 Supplement 10 p. 5352-5357
6 p.
artikel
87 The epidemiology of mumps in Italy Gabutti, G.
2008
26 Supplement 10 p. 2906-2911
6 p.
artikel
88 The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant Liu, Xiuping
2008
26 Supplement 10 p. 786-796
11 p.
artikel
89 Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: Proof of principle in two strains of rat Stathopoulos, Apostolos
2008
26 Supplement 10 p. 1764-1772
9 p.
artikel
90 Therapeutic vaccination with dendritic cells pulsed with tumor-derived Hsp70 and a COX-2 inhibitor induces protective immunity against B16 melanoma Toomey, Deirdre
2008
26 Supplement 10 p. 3540-3549
10 p.
artikel
91 The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis Derrick, Steven C.
2008
26 Supplement 10 p. 6092-6098
7 p.
artikel
92 Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis Cuppari, Anahi Fernandez
2008
26 Supplement 10 p. 5040-5045
6 p.
artikel
93 Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report But, David Yiu-Kuen
2008
26 Supplement 10 p. 6587-6591
5 p.
artikel
94 Vaccination of cattle against tropical theileriosis in Uzbekistan using autochthonous live vaccine Rasulov, Ilhan
2008
26 Supplement 10 p. G14-G16
nvt p.
artikel
95 Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers Vandepapelière, Pierre
2008
26 Supplement 10 p. 1375-1386
12 p.
artikel
96 Virus-specific intestinal IFN-γ producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs Yuan, Lijuan
2008
26 Supplement 10 p. 3322-3331
10 p.
artikel
97 Vitamin A supplements are well tolerated with the pentavalent vaccine Newton, Sam
2008
26 Supplement 10 p. 6608-6613
6 p.
artikel
                             97 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland